Expert Interview
A second look at the potential of Gepotidacin in uncomplicated urinary tract infections and the EAGLE-2 and EAGLE-3 trials of Gepotidacin compared to current standard of care, nitrofurantoin.
Ticker(s): GSKInstitution: Valley Urogynecology Associates
- experienced, board-certified urogynecologist with extensive training and knowledge in the area of pelvic floor disorders, including uterine prolapse, overactive bladder, urinary incontinence, and fecal incontinence
- offers a wide range of innovative treatments, such as bladder Botox®, sacral nerve stimulation, urethral slings, minimally invasive vaginal surgery, and other innovative options
- treats about 20 pts per month where the primary complaint is a UTI or recurrent utis
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
